Bioventus (BVS) Change in Cash (2020 - 2026)

Bioventus (BVS) has 7 years of Change in Cash data on file, last reported at -$15.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 18.04% year-over-year to -$15.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (up 650.15% YoY), and the FY2025 full-year result was $9.7 million, up 109.09% from the prior year.
• Change in Cash for Q1 2026 stood at -$15.4 million, down from $9.1 million in the prior quarter.
• Across five years, Change in Cash topped out at $15.3 million in Q2 2023 and bottomed at -$41.7 million in Q3 2022.
• The 5-year median for Change in Cash is -$2.5 million (2022), against an average of -$3.7 million.
• The widest annual swing landed in 2022, when Change in Cash tumbled 583.55%; it then jumped 708.18% in 2025.
• A 5-year view of Change in Cash shows it stood at -$2.5 million in 2022, then jumped by 498.31% to $10.1 million in 2023, then sank by 114.72% to -$1.5 million in 2024, then surged by 708.18% to $9.1 million in 2025, then slumped by 269.63% to -$15.4 million in 2026.
• The last three Change in Cash figures came in at -$15.4 million (Q1 2026), $9.1 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.

Peer Comparison